• A preliminary probabilistic nomogram model for predicting renal arteriolar damage in IgA nephropathy from clinical parameters
• Abiotrophia defectiva Endocarditis: A Case Diagnosed Incidentally Due to Multi-organ Embolism
• Acute Kidney Injury in Chronic Liver Disease in Northwest India: Still a Battle to Conquer
• Adult Henoch-Schonlein purpura complicated by IgA-nephritis in a patient with mantle cell lymphoma and Graves disease
• Advances in primary glomerulonephritis
• An Unusual Presentation of Myeloperoxidase-Associated Glomerulonephritis and Suspected IgA-Mediated Anti-Glomerular Basement Membrane Disease: A Case Report
• Analysis of IgG subclass staining for IgG immunofluorescence-positive IgA nephropathy
• Angiotensin II Type 2 Receptor Antibodies in Glomerular Diseases
• Application of the updated International IgA Nephropathy Prediction Tool in children one- or two-years post-biopsy
• B Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy
• Blood and urine biomarkers of disease progression in IgA nephropathy
• C4d, rather than C3d and C5b-9, is associated with graft loss in recurrent IgA deposition after kidney transplantation
• Cathepsin S (CTSS) in IgA nephropathy: an exploratory study on its role as a potential diagnostic biomarker and therapeutic target
• Causal associations and potential mechanisms between inflammatory skin diseases and IgA nephropathy: a bi-directional Mendelian randomization study
• Causal relationship between inflammatory skin diseases and immunoglobulin A nephropathy: A Mendelian randomization and enrichment analysis study
• Causal relationships between vitamin E and multiple kidney diseases: evidence from trans-ethnic Mendelian randomization study
• Causal role of immune cells in IgA nephropathy: a mendelian randomization study
• Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
• Characteristics and function of the gut microbiota in patients with IgA nephropathy via metagenomic sequencing technology
• Clinical features and prognosis of patients with anti-GBM disease combined with mesangial IgA deposition
• Clinical implications of C2 lesion in IgA nephropathy: A cohort study
• Clinical implications of four different nutritional indexes in patients with IgA nephropathy
• Clinical significance of glomerular IgM deposit in IgA nephropathy: a 5-year follow-up study
• Correlation of Serum Bilirubin with Clinical and Pathological Characteristics of Patients with IgA Nephropathy
• Corticosteroids in Patients With IgA Nephropathy: Is the Lower the Better?
• Crohn's Disease Associated With IgA Nephropathy Effectively Treated With the Interleukin-23 Inhibitor Risankizumab
• Current understanding and new insights in the treatment of IgA nephropathy
• De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination
• Design of a User-Centered Electronic Health Tool for Glomerular Disease Management
• Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease
• Does COVID-19 vaccination trigger gross hematuria in patients with IgA nephropathy?
• Effect of tonsillectomy combined with steroid pulse therapy upon IgA nephropathy depending on proteinuria status at diagnosis: a nationwide multicenter cohort study in Japan
• Effectiveness and Safety of Spironolactone in the Treatment of IgA Nephropathy: A Retrospective Self-Controlled Study
• Exploring macrophage heterogeneity in IgA nephropathy: Mechanisms of renal impairment and current therapeutic targets
• Exploring the crosstalk molecular mechanisms between IgA nephropathy and Sjogren's syndrome based on comprehensive bioinformatics and immunohistochemical analyses
• Features that characterize monoclonal light chain ("myeloma") cast nephropathy with immunofluorescence challenges and emphasis on electron microscopy
• Ferroptosis-Related Genes in IgA Nephropathy: Screening for Potential Targets of the Mechanism
• Galectin-3 contributes to pathogenesis of IgA nephropathy
• Glomerular Diameter Measurements on Light Microscopy: A New Parameter Available to Pathologists and its Utility in IgA Nephropathy
• Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan
• High systemic inflammatory response index (SIRI) is an independent risk factor for poor outcome in IgA nephropathy patients
• Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy
• Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy
• IgA class-switched CD27-CD21+ B cells in IgA nephropathy
• IgA nephropathy after long-term treatment with infliximab for Crohn's disease Crohn's disease, a review of two cases
• IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2
• IgA nephropathy: current treatment status, prospects, opportunities, and challenges
• IgA Nephropathy: Emerging Mechanisms of Disease
• IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings
• Immune disease dialogue of chemokine-based cell communications as revealed by single-cell RNA sequencing meta-analysis
• Immunoglobulin A vasculitis with periorbital edema and severe renal involvement: A case report
• Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy
• Infection-Associated Glomerulonephritis
• Insights on Nefecon(), a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy
• Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice
• Kidney involvement in myelodysplastic syndromes
• Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model
• Long-term outcomes of patients with IgA nephropathy in the German CKD cohort
• Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissue
• Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials
• Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis
• Mendelian Randomization Analysis of Systemic Iron Status and Risk of Different Types of Kidney Disease
• Mendelian Randomization Unveils Drug Targets for IgA Nephropathy
• Metastatic Non-Small-Cell Lung Cancer Presenting as Renal Failure From IgA Nephropathy
• Nephrology: a flourishing field with plentiful emerging topics
• Nivolumab-associated IgA Nephropathy in a Child With Malignant Melanoma
• O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy
• Outcome of Glomerular Disease Manifesting After Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2
• Overlap of membranous nephropathy and IgA nephropathy in a patient with Kimura's disease: a case report and literature review
• Pathogenesis of IgA nephropathy as a tissue-specific autoimmune disease
• Pediatric Bilateral Hypoplastic Kidney Complicated With C1q Nephropathy: A Case Report
• Predictive role of PAR and LAR in refractory suppurative meningitis in infants
• Primary IgA Nephropathy: New Insights and Emerging Therapies
• Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases
• Renal Aspergillosis Complicating Renal Allograft Transplantation: A Case Report
• Renal leukocyte chemokine type 2 amyloidosis: a clinicopathological analysis of fifteen cases
• Repurposing anti-osteoporosis drugs for autoimmune diseases: A two-sample Mendelian randomization study
• Response to the attached letter "IgA nephropathy and hematuria after getting vaccine for SARS-CoV-2" by H. Daungsupawong and V. Wiwanitkit
• Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy
• Rutin reduces inflammation and fibrosis via TGF-beta/SMAD pathways in IgA nephropathy induced rats
• SGLT-2 inhibitors: new horizons for rheumatologists
• Single-cell analysis provides new insights into the roles of tertiary lymphoid structures and immune cell infiltration in kidney injury and chronic kidney disease
• Sodium excretion per nephron and nighttime hypertension in patients with IgA nephropathy
• Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use
• Systemic autoinflammatory disease, IgA glomerulonephritis and renal cortical necrosis: coincidence or causation?
• The authors reply
• The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns
• The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy
• The genetics and epidemiology of N- and O-immunoglobulin A glycomics
• The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy
• The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy
• The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
• The significance of subclassifying focal segmental glomerulosclerosis lesions (S1) in IgA nephropathy
• The successful use of rituximab in IgA nephropathy patients with podocytopathy: a case series
• Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil
• Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues
• Unveiling Renal Lipid Deposition: A Rare Case of Hepatic Glomerulosclerosis Resembling Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency Post Liver Transplantation
• Urinary N-acetyl-D-glucosaminidase can predict bleeding after a percutaneous kidney biopsy
• Uromodulin and progression of IgA nephropathy
• Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation